🇺🇸 FDA
Patent

US 8889672

Compounds, formulations, and methods of protein kinase C inhibition

granted A61KA61K31/352A61K31/381

Quick answer

US patent 8889672 (Compounds, formulations, and methods of protein kinase C inhibition) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/352, A61K31/381, A61K31/4025, A61K31/4436